HZNP Articles, Horizon Therapeutics Public Limited Company

Horizon Therapeutics (NASDAQ:HZNP) has outperformed the market over the past 5 years by 36.06% on an annualized basis producing an average annual r...

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hig...

Horizon Therapeutics (NASDAQ:HZNP) has outperformed the market over the past 10 years by 32.84% on an annualized basis producing an average annual ...

On Friday, the U.S. Federal Trade Commission (FTC) gave a green light to Amgen Inc's (NASDAQ: AMGN) acquisition of Horizon Thera...

Horizon Therapeutics (NASDAQ:HZNP) has outperformed the market over the past 10 years by 35.51% on an annualized basis producing an average annual ...

The U.S. Federal Trade Commission (FTC) has approved drug manufacturer Amgen Inc (NASDAQ: AMGN) to proceed with its $27.8 billion acquisi...

In the current session, the stock is trading at $113.00, after a 0.36% increase. Over the past month, Horizon Therapeutics Inc. (NASDAQ:HZNP) stock...

Midday trading on Tuesday saw a rally in stocks as investors bet the Federal Reserve would hold off on raising interest rates amid the latest weak...

Sentiment going into Tuesday’s session appears to be muted, as evident from the stock futures, which were narrowly mixed. A few key economic ...

Wall Street kicked off the week positively, boosted by an improvement in global risk sentiment following China’s announcement of a 50% reduct...